Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Erratum to: Trastuzumab: a review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer

  • 598 Accesses

Article Corrected

Garnock-Jones KP, Keating GM, Scott LJ. Trastuzumab: a review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. Drugs 2010 Jan; 70 (2): 215–39

Correction Made

Page 220, table IV, ‘Concurrent studies’ section, ‘BCIRG 006’ row: The cell entry in the ‘Treatment regimen’ column, which previously read:

“• AC 60/600 mg/m2 q3w × 4 cycles → DOC 100 mg/m2 q3w × 4 cycles + concurrent TRA 6 mg/kg q1w × 12 cycles (8 mg/kg LD) → TRA 6 mg/kg q3w (total TRA treatment time of 1 y)

• DOC 75 mg/m2 + CAR AUC6 q3w × 6 cycles + concurrent TRA 6 mg/kg q1w × 18 cycles (8 mg/kg LD) → TRA 6 mg/kg q3w (total TRA treatment time of 1 y)

• AC 60/600 mg/m2 q3w × 4 cycles → DOC 100 mg/m2 q3w × 4 cycles”

has now been corrected as follows:

“• AC 60/600 mg/m2 q3w × 4 cycles → DOC 100 mg/m2 q3w × 4 cycles + concurrent TRA 2 mg/kg q1w × 12 cycles (4 mg/kg LD) → TRA 6 mg/kg q3w (total TRA treatment time of 1 y)

• DOC 75 mg/m2 + CAR AUC6 q3w × 6 cycles + concurrent TRA 2 mg/kg q1w × 18 cycles (4 mg/kg LD) → TRA 6 mg/kg q3w (total TRA treatment time of 1 y)

• AC 60/600 mg/m2 q3w × 4 cycles → DOC 100 mg/m2 q3w × 4 cycles”

Note

All online versions of this article have been updated to reflect this correction.

Additional information

An Erratum for this chapter can be found at http://dx.doi.org/10.2165/11203700-000000000-00000

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Garnock-Jones, K., Keating, G. & Scott, L. Erratum to: Trastuzumab: a review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. Drugs 71, 1578 (2011). https://doi.org/10.2165/11596220-000000000-00000

Download citation